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Endothelial cells rest on a basement membrane that 
anchors them to the vessel wall. The a6/14 integrin 
complex has been described on epithelial cells, fre-
quently localizes to basement-membrane structures, 
and appears to play a role in binding epithelial cells 
to laminin. We have determined that human micro-
vascular endothelial cells express the /14 integrin 
chain in vivo and that it preferentially localizes to the 
endothelial basement membrane. Human microvas-
cular endothelial cells and human umbilical vein 
endothelial cells also express cell-surface /14 in vitro. 
In addition, the expression of /34 appears to be polar-
ized to the undersurface o f endothelial cell monolay-
he integrin family of cell-adhesion molecules has 
been shown to play an important role in the attach-
ment of a variety of cells to basement-membrane 
proteins. Recently, an integrin subfamily containing 
the {34 subunit, with almost exclusive epithelial 
distribution, has been described [1,2] and its eDNA has been cloned 
and sequenced [3,4]. The only a subunit that has been shown to 
associate on the cell surface with the {34 chain is the 0'6 integrin 
subunit. Although a6 also may associate with {31, a6 preferentially 
associates with the {34 subunit, even in the presence of the {31 
polypeptide [5]. In many circumstances, the O'6{34 complex is 
polarized to the surface of epithelial cells that interacts with 
basement membrane. 
The O'6{34 complex has been demonstrated in epithelial cells of a 
variety of tissues [6]. Initial findings suggested that the {34 integrin 
chain was restricted almost exclusively to epithelial cells and that 
endothelial cells did not express {34-containing integrin complexes 
[6]. However, subsequent studies have suggested that at least a 
subset of endothelial cells expresses {34 [7,8]. In addition, recent 
immunofluorescence studies of normal human skin [9] clearly 
demonstrated in vivo expression of {34 integrin chain, both at the 
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ers in vitro, mimicking its in vivo localization. Stimu-
lation of microvascular endothelial cells with basic 
fibroblast growth factor or phorbol 12-myristate 13-
acetate, agents previously shown to induce endo-
thelial cell migration in vitro, resulted in a marked 
decrease in cell-surface expression of the /34 integrin 
chain, associated with a decrease in /14 mRNA. These 
data demonstrate that human endothelial cells ex-
press the /14 integrin chain in vivo and in vitro, the 
expression of this integrin chain is polarized, and its 
expression is regulated on microvascular endothelial 
cells by factors important in wound healing and vascu-
lar regeneration. J Invest Dermatol 104:266-270, 1995 
dermal-epidermal junction and around dermal blood vessels, and 
the {34 chain has been identified on cultured bovine microvascular 
endothelial cells [10]. However, the expression of {34-containing 
integrin complexes on endothelial cells has not been examined in 
cultured human endothelial cells. 
We investigated the in vivo and in vitro expression of the 0'6 and 
{34 integrin chains on human dermal microvascular endothelial cells 
(HDMEC) and examined the eifects of basic fibroblast growth 
factor (bFGF) and the protein kinase C agonist phorbol 12-
myristate 13-acetate (PMA), agents that have been shown previ-
ously to augment in vitro angiogenesis and endothelial cell migra-
tion, on the cell- surface expression of the 0'6 and {34 integrin chains 
by endothelial cells. Our data demonstrate that HDMEC express 
the {34 integrin chain in vivo and in vitro . Furthermore, {34 is 
preferentially located on the basal surface of these cells adjacent to 
basement membrane in vivo and in vitro, and the expression of 
integrins containing the {34 integrin subunit is decreased by treat-
ment of HDMEC with angiogenic factors in vitro. 
MATERIALS AND METHODS 
Immun ofluorescen c e , Immunoperoxidase and Immunoelectron 
Microscopy of Skin Normal human breast skin was collected in accor-
dance with the guidelines of the Emory University Institutional R eview 
Board. Specimens were embedded in Tissue-Tek O.C.T. compound (Miles 
Inc., Elkart, IN) and snap-frozen. Frozen sections of skin were fixed with 
acetone, incubated with 1% gelatin-phoshate-buffered saline, and then 
incubated with monoclonal antibody (MoAb) 3E1. For immunoperoxidase 
staining, the binding of antibody was detected using a three-step immuno-
peroxidase method as described [11]. Double labeling with Ulex europaeus 
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[12] and immunoelectron microscopy of human skin [13] were done as 
described previously. 
Cell Culture HDMEC were isolated and cultured as described previ-
ously [14]. Human umbilical vein endothelial cells (HUVEC) were isolated 
from collagenase-treated umbilical vein and cultured as described previ-
ously [15]. The human epidermoid carcinoma cell line A431 was obtained 
from American Type Culture Collection (ATCC, Rockville, MD). 
Antibodies and Cytokines MoAb 3E1, which recognizes the {34 inte-
grin chain, was purchased from Telios Pharmaceuticals (San Diego, CA). 
MoAb 439-9B, which also recognizes the {34 integrin chain [16], was the 
generous gift of Dr. Stephen Kennel (Oak Ridge, TN) . MoAb lOP 49f, 
which recognizes the a6 integrin chain, was purchased from AMAC Inc. 
(Westbrook, ME). Hybridomas producing MoAb 3F12 and 7G2, obtained 
from Dr. Eric Brown (Washington University, St. Louis, MO), as well as 
hybridomas producing OKT11 antibody (ATCC) were grown in our 
laboratory. MoAbs 3F12 and 7G2 have been characterized previously [17] 
and have been shown to recognize the av and {33 integrin chains, 
respectively. Monoclonal antibody MoAb 13, which recognizes the {31 
integrin, was a generous gift of Dr. Kenneth Yamada (National Institutes of 
Health, National Cancer Institute, Bethesda, MD). Recombinant bFGF was 
the generous gift of Dr. David Carmicheal (Synergen, Boulder, CO) . PMA 
was obtained from Sigma (St. Louis, MO). Interferon-y was obtained from 
Genentech (South San Francisco, CA) . 
Enzyme Linked Immunosorbent Assay (ELISA) Cell-surface expres-
sion ofintegrins was determined by ELISA as described previously [18]. To 
access the basal surface of the endothelial cells, mono layers were fixed for 
5 min with 3% paraformaldehyde. The plates were then washed, incubated 
with 1% Triton X-100 for 3 min on ice, and then washed again with Hanks' 
balanced salt solution. After the integrity of the endothelial cell monolayers 
was checked, the cells were examined by ELISA as described previously. 
Flow Cytometric Analysis HDMEC, plated in six-well plates or T -25 
flasks and allowed to grow to confluence for 24 h, were stimulated as 
described above. After stimulation, the cells were removed with trypsin/ 
ethylenediaminetetraacetic acid, washed, suspended in phosphate-buffered 
saline with 0.5% bovine serum albumin, and aliquoted into Eppendorftubes 
for staining. In some experiments, cells were fixed briefly with 3% 
paraformaldehyde, washed, and permeabilized with 1 % Triton X-100. Cells 
were then washed, resuspended in phosphate-buffered saline with 0.5% 
bovine serum albumin, stained, and examined by flow cytometric analysis as 
described previously [12]. 
Isolation of Total Cellular RNA for Northern and Slot Blot Analysis 
Total cellular RNA was isolated from experimental cells by guanidinium 
isothiocyanate lysis and CsCL density gradient pelleting [19,20]. For 
Northern blot analysis, equal quantities of RNA samples (10 fJ-g) were 
fractionated over formaldehyde/agarose gels, transferred to Nytran (Schlei-
cher & Schuell, Keene, NH) nylon membranes, and then ultraviolet 
cross-linked to membranes using an automated ultraviolet exposure device 
(Stratagene, La Jolla, CA). For slot blot analysis, 6 fJ-g of total cellular RNA 
dissolved in 10 fJ-I of distilled water was mixed with 20 fJ-I of formamide, 7 
fJ-I of 37% formaldehyde, and 2 fJ-I of 20 X sodium chloride/sodium citrate 
buffer and heated for 15 min at 68°C. The mixture was then cooled on ice, 
and 30 fJ-I of20 X sodium chloride/sodium citrate buffer was added to each 
sample. Each sample was then loaded onto nitrocellulose filters (Micron 
Separations Inc., Westboro, MA) using a slot blot apparatus (Schleicher and 
Schuell) according to the manufacturer' s instructions, and then ultraviolet 
cross-linked to membranes using an automated ultraviolet exposure device 
(Stratagene) . Membranes were prehybridized and then hybridized over-
night at 42°C with 20 ng of randomly primed 32P-Iabeled cDNA fragments 
for the {34 chain (generous gift from Dr. Shintaro Suzuki, Doheny Eye 
Institute, Los Angeles, CA) [3] (specific activities 108 to 109 cpm/ fJ-g) . 
Probed membranes were washed and exposed to x-ray film (Hyperfilm, 
Amersham). After hybridization with specific {34 cDNA probe, membranes 
were stripped and rehybridized with a {3-actin cDNA fragment. Two-
dimensional autoradiographic densitometry with background subtraction 
was performed using NIH Image software (version 1.35) and a LaCie 1200 
dpi color scanner interfaced with a MacIntosh Hcx. 
RESULTS 
HDMEC express the /34 integrin chain in vivo Two-color 
immunofluorescence microscopy using double staining with the 
134-specific MoAb 3El and the endothelial-cell-specific lectin Ulex 
europaeus demonstrated co-localization of 134 integrin with Ulex-
binding blood vessels (Fig 1a,b). In addition, sections of normal 
breast skin stained with MoAb 3El and examined by immunoper-
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oxidase clearly demonstrated that endothelial 134 expression was 
associated primarily with the abluminal basement-membrane-asso-
ciated surface of the endothelial cells (Fig 1t). Immunoelectron 
microscopic examination of skin specimens demonstrated a similar 
localization of 134 expression on the basal surface of keratinocytes 
(Fig 2a) and endothelial cells (Fig 2b). These data suggest that 
HDMEC in skin express the 134 integrin chain in vivo in a polarized 
manner similar to that seen in epithelial cells. 
HDMEC and HUVEC Express the /34 Integrin Chain in vitro 
To determine whether endothelial cells also express the 134 integrin 
chain in vitro, we examined cultured large- and small-vessel endo-
thelial cells by flow cytometry. HDMEC (Fig 3) and HUVEC (data 
not shown) express cell-surface 134 integrin in vitro, although 
cell-surface expression of the 134 integrin chain was markedly less 
than cell-surface 131 integrin expression. 
/34 Expression on HDMEC is Polarized to the Undersurface 
of Endothelial Cell Monolayers When cell-surface expression 
of 134 on HD MEC was examined by ELISA, unexpectedly no 
cell-surface expression was detected. Because 134 expression was 
polarized in vivo to the abluminal surface of cells, we examined 
whether our inability to detect 134 by ELISA was due to similar 
polarized expression in vivo. In that case, 134 expression would be 
limited to those portions of the cell membrane involved in attach-
ment to the culture plate and thus would be inaccessible to the 
antibodies in live unfixed cells. To access the undersurface of 
monolayers, cell layers were fixed and permeabilized, and expres-
sion was again examined by ELISA. Using this technique, we 
determined that the detection of both a6 and 134 integrin subunits 
was markedly increased in permeabilized HDMEC monolayers 
(Fig 4). In contrast, the detection of cell-surface av was not 
affected by fixation and permeabilization. These data suggest that 
the 134 integrin chain is expressed in a polarized fashion on the 
undersurface of endothelial cell mono layers in vitro, mostly likely in 
a complex with the a6 integrin chain. 
To demonstrate that the fixation and permeabilization of 
HDMEC actually exposed 134 on the underside of cells and did not 
expose an intracellular pool of antigen, we examined fixed and 
permeabilized HDMEC by flow cytometric analysis. The expres-
sion of the 134 integrin chain was unchanged in the fixed and 
permeabilized cells as compared to control, nonpermeabilized cells 
(data not shown). In contrast, HDMEC fixed, permeabilized, and 
stained with MoAb recognizing the 133 integrin clearly demon-
strated increased fluorescence intensity, indicating an intracellular 
pool of 133 integrin. This finding was described previously [12]. 
PMA and bFGF Decrease HDMEC Expression of /34 and a6 
The polarized expression of 134 integrins suggested a possible role 
for the a6134 complex in endothelial cell anchorage to basement 
membrane. We reasoned that if such were the case, modulation of 
a6134 expression and/or binding function would likely be required 
for migration to occur. We therefore examined the effects of agents 
that have been shown previously to increase endothelial cell 
migration on the expression of the 134 and a6 integrin chains on 
HDMEC. We determined the effects ofbFGF or PMA on HDMEC 
integrin expression by both flow cytometric analysis and ELISA. 
Examination ofHDMEC stimulated with either bFGF (1 jLg/rnl X 
72 h) or PMA (100 ng/rnl X 72 h) by flow cytometric analysis 
demonstrated decreased cell-surface expression of both the 134 and 
the a6 (data not shown) integrin chains. Similarly, HDMEC 
stimulated with either PMA or bFGF demonstrated decreased 134 
expression when examined by modified ELISA (Fig 5). The 
decreases in 134 expression induced by bFGF (Fig 6a,b) were dose-
and time-dependent. Decreases in 134 expression were detectable 
after 24 h of stimulation, and levels continued to decrease up to 
72 h. Decreases in expression were seen at doses ofbFGF as low as 
1 ng/ml and were maximal at doses of 1000 ng/ml. 
HDMEC Express /34 mRNA, and /34 mRNA Expression Is 
Decreased by PMA and bFGF Using a 134-specific eDNA 
probe, we detected the 6-kb 134 mRNA on unstimulated HDMEC. 
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Figure 1. The /34 integrin chain is expressed on cutaneous microvessels in vivo. Frozen sections of human breast skin were double stained with Ulex 
europaeusl (a) and MoAb 3El (anti-/34 integrin antibody, b and c) and examined by immunofluorescence (a and b, bar, 64 /J.m) or immunoperoxidase (c, bar, 6 fLm). 
The detected mRNA species was the size of the {34 mRNA 
detected in A431 cells, which supports the likelihood that it is 
authentic {34 mRNA. However, the relative amount of {34 mRNA 
in HDMEC per }.Lg of total RNA is clearly much less than the {34 
mRNA levels observed in A431 cells (Fig 7), which correlates well 
with differences in cell-surface expression observed in these two 
cell types. Stimulation of HDMEC with bFGF or PMA resulted in 
more than an 80% decrease of expression of {34 mRNA (Fig 8). 
HDMEC also were stimulated with interferon-y, which has been 
shown to decrease expression of cell-surface av{33 complex and {33 
mRNA [21]. Interferon-y had no effect on cell-surface expression 
of the {34 integrin chain in HDMEC (R. Swerlick, unpublished 
observation) and similarly had no effect on {34 mRNA expression. 
These data demonstrate that HDMEC express {34 integrin mRNA, 
that PMA and bFGF decrease (34 mRNA in a cytokine-specific 
Figure 2. The /34 integrin chain is asso ciated with epid ermal and 
microvascular basement memb rane in human skin. Immunoelectron 
microscopic analysis of normal human skin demonstrated staining both of 
the basal surface of basal keratinocytes (a) and the abluminal surface of 
endothelial cells (b) with anti-/34 integrin antibody. Bar, 0.17 fLm). 
manner, and that the regulation of {34 mRNA expression ill 
response to bFGF and PMA parallels the changes observed ill 
cell-surface expression. 
DISCUSSION 
The {34 integrin chain was described originally as an epithelial-
specific integrin chain [1,2]. However, recent studies of various 
tissues using immunohistochemical techniques have suggested that 
under certain circumstances, the a6/ {34 complex may be expressed 
by a much broader variety of cell types. We have confirmed 
previous observations [9J that human skin endothelial cells express 
the {34 integrin chain in vivo, and that cultured endothelial cells also 
express the {34 integrin in vitro [10]. In addition, we demonstrated 
that the {34 integrin chain appears to be polarized to the ablurninal 
surface of endothelial cells in vivo, that this polarized phenotype is 
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Figure 3. HDMEC express the /34 integrin chain in vitro: d e mon-
st ration b y flow cytometric analy sis. HDMEC were stained with 
isotype control (unstained), MoAb 13 recognizing the bl integrin, or MoAb 
3El recognizing the /34 integrin chain, and evaluated by flbw cytometry. 
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Figure 4. HDMEC express the 134 and a6 integrin chains in vitro: 
demonstration by modified ELISA. Expression of the {34, 0'6, and O'V 
integrin chains on non-permeabilized (solid bars) and permeabilized (shaded 
bars) HDMEC monolayers. Results represent the mean ± standard devia-
tion of four values from a single experiment. 
conserved in vitro, and that cell-surface and mRNA expression of 
both the {34 and a6 integrins can be modulated by bFGF and PMA 
in vitro. 
In epithelial celis, a6/ (34 co-localizes to hemidesmosomal struc-
tures [22]. However, hemidesmosomes have not been identified in 
endothelial celis. The in vivo ligand for the a6{34 complex has not 
been defmed fuUy, although the complex has been shown to 
function as a receptor for laminin [23] in colon carcinoma cells. 
Although the in vivo ligand for the a6{34 complex is unknown, its 
polarization to the basal surface of keratinocytes juxtaposed to the 
basement membrane [24] and its co-localization with hemidesmo-
somes [21] suggest an important role in cell-basement-membrane 
interactions. The polarization of the a6{34 complex to the ablumi-
nal side of endothelial cells juxtaposed to the basement membrane 
also provides evidence that it may play an important role in the 
interaction of endothelial cells with basement membrane and 
suggests that a structure analogous to the hemidesmosome also may 
be present on endothelial cells. 
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Figure 5. Both bFGF and PMA decrease the cell-surface expression of 
134 and a6 integrins on HDMEC. HDMEC were stimulated with bFGF 
(1 JLg/rnl X 72 h) or PMA (100 ng/ml X 72 h) and evaluated for cell surface 
expression by modified ELISA for 0'6 and {34 integrins. Results represent the 
mean ± standard deviation of four values from a single experiment. 
MICROVASCULAR EXPRESSION OF THE cx6{34 COMPLEX 269 
0.125 
A 
0.100 
E 
s:: 0.075 0 
'l') 
'III:t 
. 0.050 Q 
. 
0 
0.025 
0.000 I 
0 20 40 60 80 
Hours 
0.150 
0.125 
0.100 
E 
s:: 
0 0.075 
'l') 
'III:t 
. 0.050 C 
. 
0 
0.025 
0.000 
-1 T""' 0 0 0 0 0 
0 0 T""' 0 0 0 0 . 
0:: 0 0 T""' 0 0 0 
..... 
T""' 0 0 
Z T""' 0 
0 T""' 
u bFGF (ng/ml) 
Figure 6. bFGF induces decreased 134 integrin expression on 
HDMEC. A) Time course. HDMEC were stimulated with bFGF (1 JLg/ml) 
for 1-72 h and evaluated for cell-surface expression by modified ELISA 
(*p < 0.05). B) Concentration dependence . HDMEC were stimulated with 
doses ofbFGF from 10 ng/ml to 1 JLg/ml for 72 h and evaluated for cell-surface 
expression by the modified ELISA (*p < 0.05). Results represent the mean 
± standard deviation of four values from a single experiment. 
It is intriguing that bFGF and PMA, factors previously shown to 
stimulate endothelial cell migration, also induced a marked down-
regulation of cell-surface expression of both a6 and {34 on 
HDMEC. In HDMEC, the decrease of cell-surface {34 is accompa-
A B 
~-Actin 
Figure 7. HDMEC express 134 
mRNA. Total cellular RNA was 
extracted from A431 (A) and un-
stimulated HDMEC (B). Ten mi-
crograms RNA each was trans-
ferred to nylon membranes and 
probed with the {34 cDNA probe 
followed by stripping and reprob-
ing with a {3-actin cDNAprobe. 
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Figure 8. PMA and bFGF down-regulate /34 mRNA. Total RNA was 
extracted from unstimulated HDMEC (A), HDMEC stimulated with 
interferon-y (1000 U/mJ X 48 h) (B), HDMEC stimulated with bFGF (1 
ug/ml X 48 h) (C), or HDMC stimulated with PMA (100 ng/ml X 48 h) 
(D) , and the expression of {34 mRNA was determined by slot blot analysis 
(see Materials an.d Methods). Membranes were then stripped and rehybridized 
with a {3-actin cDNA fragment to assess uniformity of RNA loading and 
transfer. Relative expression (in arbitrary units) of {34 mRNA was assessed 
by densitometric analysis and corrected for loading differences (bottom). 
rued by a marked decrease in steady-state {34 mRNA, and this 
decrease is likely regulated transcriptionally. However, previous 
studies have shown that bFGF stimulation of bovine adrenal cortex 
endothelial cells induces an increase in {34 expression [10]. In these 
same cells, bFGF induced decreased av{33 expression and increased 
a3{31 expression [10], a result that is completely the opposite from 
that observed in HDMEC [12,21]. These studies suggest that there 
is heterogeneity of microvascular endothelial cells from different 
species or anatomic sites. 
The a6{34 complex co-localizes with the a3{31 complex on the 
basal surface of keratinocytes [25]. In addition, studies examining 
the migration of human keratinocytes have demonstrated that 
treatment with anti-a3 MoAb results in increased cell migration 
[26]. Similarly, the {34 and a3 integrin chains are co-regulated in 
HDMEC. Stimulation of HDMEC with bFGF or PMA also results 
in decreased expression of a3{31 [12]. Modulation of these integrin 
complexes may be critical when endothelial cells are recruited into 
areas to form new blood vessels. 
These data demonstrate that exposure of HDMEC to growth 
factors such as bFGF results in changes in the expression of 
cell-surface {34 integrin chain. Stimulation with bFGF in culture 
may be comparable to conditions in vivo in which microvascular 
endothelial cells are called upon to migrate and form new blood 
vessels. Previous studies have demonstrated clearly that bFGF 
stimulation of microvascular endothelial cells alters integrin expres-
sion [12,24] and increases endothelial cell migration [27,28]. These 
functional changes may result from acquisition of a "migratory 
phenotype" of integrin expression, a phenotype that may be 
uniquely suited for endothelial cell migration in injured tissues and 
for the formation of new microvessels. 
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